等待开盘 03-27 09:30:00 美东时间
+1.880
+0.99%
New Phase 1b data support the safety and effectiveness of salanersen over one year in children with SMA who had the potential for improvement due to suboptimal clinical status with prior gene therapySalanersen is a novel
03-11 20:04
Biogen Inc. (NASDAQ:BIIB) on Friday reported better-than-expected fourth-quarte...
02-09 21:36
Biogen beat fourth-quarter earnings and revenue estimates as growth from Leqembi, Skyclarys, and Zurzuvae offset declining multiple sclerosis sales, while the company forecast higher 2026 earnings.
02-06 23:33
Biogen (NASDAQ:BIIB) announced its Q4 earnings on Friday, February 6, 2026 at 0...
02-06 19:06
U.S. stock futures down; AutoNation, Amazon, Philip Morris, Reddit, and Biogen expected to report quarterly earnings.
02-06 14:41
Biogen (NASDAQ:BIIB) is preparing to release its quarterly earnings on Friday, ...
02-05 22:02
This whale alert can help traders discover the next big trading opportunities. ...
01-16 01:35
Johnson & Johnson reported encouraging Phase 2 results for its experimental lupus drug nipocalimab in patients with SLE.
01-07 02:42
As a result of the reconstitution, the following six companies will be removed from the Index: Biogen Inc. (NASDAQ:BIIB), CDW Corporation (NASDAQ:CDW), GlobalFoundries Inc. (NASDAQ:GFS), Lululemon Athletica Inc.
2025-12-15 16:10
Biogen stock rises as Novo Nordisk's Alzheimer's trials disappoint, spotlighting Leqembi's role and a new immunology collaboration with Dayra Therapeutics.
2025-11-25 00:17